DULCOLAX- bisacodyl suppository United States - English - NLM (National Library of Medicine)

dulcolax- bisacodyl suppository

boehringer ingelheim pharmaceuticals, inc. - bisacodyl (unii: 10x0709y6i) (deacetylbisacodyl - unii:r09078e41y) - drug facts use - for temporary relief of occasional constipation and irregularity - this product generally produces bowel movement in 15 minutes to 1 hour warnings for rectal use only ask a doctor before use if you have - stomach pain, nausea or vomiting - a sudden change in bowel habits that lasts more than 2 weeks when using this product it may cause stomach discomfort, faintness, rectal burning and mild cramps stop use and ask a doctor if - you have rectal bleeding or no bowel movement after using this product. these could be signs of a serious condition. - you need to use a laxative for more than 1 week if pregnant or breast-feeding, ask a health professional before use. keep out of reach of children. if swallowed, get medical help or contact a poison control center right away. directions other information - store at 20°-25°c (68°-77°f) inactive ingredient hard fat questions? call 1-888-285-9159 (english/spanish), m – f, 8:30 – 5 est, or visit www.dulcolax.com distributed by: boehringer ingelheim

Dulcolax SP Drops New Zealand - English - Medsafe (Medicines Safety Authority)

dulcolax sp drops

pharmacy retailing (nz) ltd t/a healthcare logistics - sodium picosulfate monohydrate 7.5 mg/ml;   - oral solution - 7.5 mg/ml - active: sodium picosulfate monohydrate 7.5 mg/ml   excipient: citric acid monohydrate purified water sodium benzoate sodium citrate dihydrate sorbitol - for the treatment of constipation

DULCOLAX FOR WOMEN TABLET Canada - English - Health Canada

dulcolax for women tablet

sanofi consumer health inc - bisacodyl - tablet - 5mg - bisacodyl 5mg - cathartics and laxatives

DULCOLAX SP DROPS 7.5mg/mL sodium picosulfate oral liquid bottle Australia - English - Department of Health (Therapeutic Goods Administration)

dulcolax sp drops 7.5mg/ml sodium picosulfate oral liquid bottle

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - sodium picosulfate, quantity: 7.5 mg/ml - oral liquid - excipient ingredients: citric acid monohydrate; sodium benzoate; purified water; sodium citrate dihydrate; sorbitol solution (70 per cent) (non-crystallising) - for the treatment of constipation

DULCOLAX Tab. 5 mg Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

dulcolax tab. 5 mg

شركة مستودع الادوية العربي - the arab drug store p.s.c - bisacodyl 5 mg - 5 mg